Dr. Stephen Squinto is the Chief Investment Officer at J. P. Morgan Life Sciences Private Capital, bringing over 30 years of biotechnology industry experience. A co-founder of Alexion Pharmaceuticals, he previously led its global R&D and operations. He holds a Ph. D. from Loyola University Chicago.
He was instrumental in co-founding Alexion Pharmaceuticals, a major biopharmaceutical company known for developing transformative drugs for rare diseases.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.